237 related articles for article (PubMed ID: 9062112)
1. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.
Liu R; Sharom FJ
Biochemistry; 1997 Mar; 36(10):2836-43. PubMed ID: 9062112
[TBL] [Abstract][Full Text] [Related]
2. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
Liu R; Sharom FJ
Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
[TBL] [Abstract][Full Text] [Related]
3. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.
Qu Q; Russell PL; Sharom FJ
Biochemistry; 2003 Feb; 42(4):1170-7. PubMed ID: 12549939
[TBL] [Abstract][Full Text] [Related]
4. Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study.
Liu R; Sharom FJ
Biochemistry; 1998 May; 37(18):6503-12. PubMed ID: 9572868
[TBL] [Abstract][Full Text] [Related]
5. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the nucleotide binding properties of SV40 T antigen using fluorescent 3'(2')-O-(2,4,6-trinitrophenyl)adenine nucleotide analogues.
Huang SG; Weisshart K; Fanning E
Biochemistry; 1998 Nov; 37(44):15336-44. PubMed ID: 9799494
[TBL] [Abstract][Full Text] [Related]
7. Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter.
Russell PL; Sharom FJ
Biochem J; 2006 Oct; 399(2):315-23. PubMed ID: 16803457
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence of native single-Trp mutants in the lactose permease from Escherichia coli: structural properties and evidence for a substrate-induced conformational change.
Weitzman C; Consler TG; Kaback HR
Protein Sci; 1995 Nov; 4(11):2310-8. PubMed ID: 8563627
[TBL] [Abstract][Full Text] [Related]
9. FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.
Qu Q; Sharom FJ
Biochemistry; 2001 Feb; 40(5):1413-22. PubMed ID: 11170469
[TBL] [Abstract][Full Text] [Related]
10. Binding of steroid modulators to recombinant cytosolic domain from mouse P-glycoprotein in close proximity to the ATP site.
Dayan G; Jault JM; Baubichon-Cortay H; Baggetto LG; Renoir JM; Baulieu EE; Gros P; Di Pietro A
Biochemistry; 1997 Dec; 36(49):15208-15. PubMed ID: 9398248
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides.
Göttle M; Dove S; Steindel P; Shen Y; Tang WJ; Geduhn J; König B; Seifert R
Mol Pharmacol; 2007 Sep; 72(3):526-35. PubMed ID: 17553924
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide binding to the multidrug resistance P-glycoprotein as studied by ESR spectroscopy.
Delannoy S; Urbatsch IL; Tombline G; Senior AE; Vogel PD
Biochemistry; 2005 Oct; 44(42):14010-9. PubMed ID: 16229490
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the binding of the fluorescent ATP analog TNP-ATP to insulysin.
Yao H; Hersh LB
Arch Biochem Biophys; 2006 Jul; 451(2):175-81. PubMed ID: 16723115
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides.
Liu R; Siemiarczuk A; Sharom FJ
Biochemistry; 2000 Dec; 39(48):14927-38. PubMed ID: 11101309
[TBL] [Abstract][Full Text] [Related]
15. Overexpression, purification and characterization of a hexahistidine-tagged recombinant extended nucleotide-binding domain 1 (NBD1) of the Cryptosporidium parvum CpABC3 for rational drug design.
Lawton P; Pélandakis M; Pétavy AF; Walchshofer N
Mol Biochem Parasitol; 2007 Mar; 152(1):101-7. PubMed ID: 17222922
[TBL] [Abstract][Full Text] [Related]
16. ATP hydrolysis promotes interactions between the extracellular ends of transmembrane segments 1 and 11 of human multidrug resistance P-glycoprotein.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2005 Aug; 44(30):10250-8. PubMed ID: 16042402
[TBL] [Abstract][Full Text] [Related]
17. Kinetic mechanisms of the nucleotide cofactor binding to the strong and weak nucleotide-binding site of the Escherichia coli PriA helicase. 2.
Lucius AL; Jezewska MJ; Roychowdhury A; Bujalowski W
Biochemistry; 2006 Jun; 45(23):7217-36. PubMed ID: 16752912
[TBL] [Abstract][Full Text] [Related]
18. The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2004 Sep; 43(38):12081-9. PubMed ID: 15379547
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2007 Aug; 46(32):9328-36. PubMed ID: 17636884
[TBL] [Abstract][Full Text] [Related]
20. Cysteine-reactive fluorescence probes of catalytic sites of ATP synthase.
Weber J; Bijol V; Wilke-Mounts S; Senior AE
Arch Biochem Biophys; 2002 Jan; 397(1):1-10. PubMed ID: 11747304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]